Drug Type Small molecule drug |
Synonyms Bactil, Bromselon, Ebastine (JP17/USAN/INN) + [20] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Spain (01 Jan 1990), |
Regulation- |
Molecular FormulaC32H39NO2 |
InChIKeyMJJALKDDGIKVBE-UHFFFAOYSA-N |
CAS Registry90729-43-4 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Conjunctivitis, Allergic | China | - | 16 May 2000 |
| Dermatitis | Japan | 16 Apr 1996 | |
| Eczema | Japan | 16 Apr 1996 | |
| Prurigo | Japan | 16 Apr 1996 | |
| Pruritus | Japan | 16 Apr 1996 | |
| Urticaria | Japan | 16 Apr 1996 | |
| Chronic Urticaria | Spain | - | 01 Jan 1990 |
| Rhinitis, Allergic | Spain | - | 01 Jan 1990 |
Phase 4 | - | iagfcoihhd(ysehkdhrmk) = pexdsnkwis deotxvhaqq (uojhpgazic ) | - | 01 Apr 2016 | |||
Placebo | iagfcoihhd(ysehkdhrmk) = lcxhbvsqrk deotxvhaqq (uojhpgazic ) | ||||||
Phase 3 | - | qsmadtqygm(dprcgqztxc) = yicxoszssn gjeaabarua (owbetbbloq ) | Positive | 01 Jul 2004 | |||
Placebo | qsmadtqygm(dprcgqztxc) = ixdmjqatea gjeaabarua (owbetbbloq ) |





